Syzygium corticosum
Syzygium corticosum · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Syzygium corticosum is a botanical species that has gained scientific interest due to its diverse pharmacological potential. Research focusing on the chloroform extract of its leaves and twigs has revealed a rich profile of bioactive secondary metabolites. These include key chemical constituents such as aromatic aldehydes, cyclohexanone, and various triterpenoids. Preliminary studies highlight the plant's significant biological activities, specifically its cytotoxic properties. Consequently, these findings suggest that the species holds great promise for further investigation in anticancer drug development.
- Synonyms
- Eugenia Corticosa
- Common names
- Not available
- Family
- Myrtaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Syzygium corticosum is a botanical species that is often identified by different names in scientific literature. In many taxonomic records, you will find it listed under the synonym Eugenia corticosa. This overlap in nomenclature can sometimes cause confusion for researchers and botanists studying its unique properties. Understanding these linguistic connections is essential for ensuring accuracy when documenting the plant's distribution and characteristics. Recognizing both names allows for a more cohesive approach to studying this specific member of the Myrtaceae family.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Syzygium corticosum belongs to the vast kingdom Plantae, representing the diverse life forms found within the natural world. This specific species is classified under the class Equisetopsida, showcasing its fundamental botanical structure. Within this framework, it is nested in the order Myrtales, which helps scientists understand its evolutionary lineage. It further belongs to the prominent family Myrtaceae, a group known for its distinct floral and leaf characteristics. Ultimately, this plant is a member of the genus Syzygium, a designation that defines its close biological relationships with similar species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Myrtaceae |
| Genus | Syzygium |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Syzygium corticosum is a plant species primarily found within the lush, tropical regions of Asia. Its natural distribution spans across the diverse landscapes of Indo-China, making it a significant part of the local flora. Specifically, this species can be found thriving throughout the various ecosystems of Thailand. It also maintains a notable presence across the verdant terrain of Vietnam. Together, these geographic ranges highlight the plant's importance within the broader tropical environment of the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Syzygium corticosum is a self-supporting plant that maintains its own structural integrity without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Syzygium corticosum has emerged as a significant subject of interest in the ongoing search for new anticancer agents derived from higher plants. Research conducted on chloroform extracts from the leaves and twigs of this species has demonstrated notable activity against the HT-29 human colon cancer cell line. Scientific investigations identified several natural products within the plant, highlighting its diverse chemical profile. Notably, (+)-ursolic acid was discovered to be the major cytotoxic component of the species. These findings underscore the potential of Syzygium corticosum as a valuable resource in pharmaceutical development.
Compounds
Conditions
Syzygium corticosum exhibits significant medicinal potential through its ability to treat the HT-29 human colon cancer cell line. Research indicates that chloroform extracts from the leaves and twigs of this plant are highly active against these specific cancer cells. Furthermore, the plant contains bioactive components, such as (+)-ursolic acid, that effectively treat NF-κB by inhibiting its activity. This same component also serves to treat mitochondrial transmembrane potential (MTP) through potent inhibitory action. Together, these biological activities highlight the plant's multifaceted role in targeting cancer-related pathways.
Preparations
Syzygium corticosum is prepared as a chloroform extract using its leaves and twigs. This specific preparation was collected in Vietnam to facilitate the search for new anticancer agents. The resulting chloroform extract demonstrated significant activity against the HT-29 human colon cancer cell line. Through the separation of this extract, researchers were able to isolate various natural products, including several triterpenoids. This extraction process ultimately allowed for the identification of (+)-ursolic acid as a major cytotoxic component.
Parts used
Syzygium corticosum serves as a significant botanical source for the discovery of potent anticancer agents. Researchers have focused specifically on the plant's leaves and twigs to extract bioactive compounds through chloroform processing. This specialized leaf extract has demonstrated notable activity against the HT-29 human colon cancer cell line. Through detailed chemical separation, scientists identified various natural products, most notably the major cytotoxic component (+)-ursolic acid. These findings highlight the medicinal importance of utilizing the leaf components of this species for pharmaceutical development.